Sacubitril valsartan trisodium hemipentahydrate is a novel, stable supramolecular salt complex (specifically, a co-crystal) that functions as a single Active Pharmaceutical Ingredient (API). Its therapeutic use is listed as antihypertensives. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include LCZ696 trisodium hemipentahydrate and Sacubitril–valsartan trisodium salt hydrate.
Sacubitril valsartan trisodium hemipentahydrate
| CAS No | 936623-90-4 |
|---|---|
| Molecular Formula | C48H55N6O8Na3⋅2.5H2OC |
| Molecular Weight | 957.99 g/mol |
| Synonyms | hexasodium;bis(4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate);bis((2S)-3-methyl-2-[pentanoyl-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]amino]butanoate);pentahydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Sacubitril valsartan trisodium hemipentahydrate is a novel, stable supramolecular salt complex (specifically, a co-crystal) that functions as a single Active Pharmaceutical Ingredient (API).
The listed CAS number is 936623-90-4.
The listed molecular formula is C48H55N6O8Na3⋅2.5H2OC.
The listed molecular weight is 957.99 g/mol.
hexasodium;bis(4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate);bis((2S)-3-methyl-2-[pentanoyl-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]amino]butanoate);pentahydrate.
The source lists LCZ696 trisodium hemipentahydrate and Sacubitril–valsartan trisodium salt hydrate.